I receive funding from an organisation defined as an eligible funder which supports the establishment / running of a tissue bank, a disease registry, data bank, cohort or other resource which underpins a number of research studies, is this eligible for adoption onto the Health and Social Care Portfolio?
Once a study is open and recruiting, recruitment activity should be uploaded to the Central Portfolio Management System on a monthly basis. More information is available here.
Recruitment activity should be attributed to the location where informed consent has been taken. Where this is a non-NHS site but consent is being obtained by NHS staff, guidance should be sought from the Portfolio Team email@example.com when adding the site to the CPMS record.
Yes, the purpose of Support and Delivery funding is to ensure that all high quality research, funded by eligible funders that involves NHS patients, their data or tissues/samples or their carers and/or NHS resources (i.e. staff, premises or facilities) has access to NHS infrastructure for research, including NHS Support Costs. Studies which include NHS patients, some or all of whom are being cared for in a private (or other non-NHS) setting, and whose care is being funded by the NHS, are eligible for Support and Delivery infrastructure support (providing they meet all other eligibility criteria).
No, in order to be considered for adoption onto the Health and Social Care Portfolio the activity must be a research project. A “research project” is defined as a structured activity which is intended to provide new knowledge which is generalisable. The establishment and running of tissue banks or disease registries does not, in itself, constitute a research project (as there is no “research question”) and these activities are therefore not eligible for support. However, activities such as the collection and banking of biological samples, inclusion of patient details on a registry, or development of a patient cohort, which form an integral part of a structured research project, or research projects which utilise such resources, are eligible for support from the Support and Delivery infrastructure (subject to meeting the other eligibility criteria) via NHS R&D allocations. Researchers are therefore invited to register their involvement in biobanks and /or Research Data Registries on the Research Directory.
No, UK universities, colleges and local healthcare organisations (including NHS Health Boards) do not fulfil the criteria for eligible funders. Studies funded by these organisations are therefore not eligible for Support and Delivery infrastructure support.
The list of Health and Care Research Wales eligible funders and their associated funding schemes is updated regularly and is available here.
Investigator-initiated, commercial collaborative studies are potentially eligible for adoption onto the Health and Social Care Portfolio, providing the funding opportunity was open to all qualified researchers in Wales.
Further information regarding investigator-initiated, commercial collaborative studies and other potentially eligible non-commercial studies can be found in the Health and Social Care Portfolio eligibility criteria.
Individual studies funded as part of programme or centre grants are required to have undergone protocol peer review before they can be considered for adoption onto the Health and Social Care Portfolio. The study sponsor should provide confirmation of appropriate peer review.
Individual studies funded as part of research training awards are required to have undergone protocol peer review before they can be considered for adoption onto Health and Social Care Portfolio. The study sponsor should provide confirmation of appropriate peer review. Eligibility for support is determined on a study-by-study basis, with emphasis on the study rather than the activity of an individual.
If your personal award is funded as an Investigator Initiated Trial, by an overseas government or overseas charity, the study will require formal consideration through the Health and Social Care Portfolio (non-commercial) adoption process. Confirmation that the specific project has been subject to high quality peer review will be required (as set out in the eligibility criteria).
Studies that are funded by overseas governments are considered for eligibility for Support and Delivery infrastructure support via the non-commercial Health and Social Care Portfolio. Studies need to demonstrate that they meet the eligibility criteria. In order to meet the criteria of open competition and high quality peer review, the funding call from the overseas government must have been open to all qualified individuals in Wales.
Studies that are funded by a non-UK charity are considered for eligibility for adoption onto the Health and Social Care Portfolio. Studies need to demonstrate they meet the eligibility criteria. In order to meet the criteria of open competition and high quality peer review, the funding call from the non-UK charity must have been open to all qualified individuals in Wales.
Yes, however the study would still need to demonstrate they meet the eligibility criteria. A study being conducted within the Health and Care Research Wales Centre/Unit/Infrastructure would not be a determining factor.
Experimental Cancer Medicine Centres (ECMCs) are funded jointly by Cancer Research UK (CR-UK), the Health and Care Research Wales, and the Health Departments for Scotland, England and Northern Ireland.
Funding is not intended to meet the direct research costs of individual studies. As CR-UK is a Health and Care Research Wales non-commercial partner, all studies supported by an ECMC award are technically eligible for consideration for Support and Delivery Infrastructure support and hence inclusion in the Health and Social Care Portfolio. However, as funding for ECMCs includes some funding for NHS support, “additional” NHS support from the Support and Delivery infrastructure will be considered on a case-by-case basis at a local level. If deemed eligible for support, these studies will be added to the Health and Social Care Portfolio. Recruitment data should be provided for all UK sites (i.e. ECMC sites and non-ECMC sites).
The Support and Delivery infrastructure ensures all high quality research that involves NHS patients (or their data or tissues/samples) or their carers, NHS staff and / or resources, has access to NHS infrastructure for research (including NHS Support Costs). If the public health intervention takes place in an NHS setting, or involves subjects who are recruited in their capacity as NHS patients, or NHS staff, then the study is eligible for support (subject to meeting all other eligibility criteria).
Where it is clear from the protocol that participants will be referred to services via the NHS and where there is a clear need for Support and Delivery infrastructure support, these studies should be considered for support (subject to meeting the usual eligibility criteria), even where the research is taking place in non-NHS settings.
Capturing all high quality studies that do not incur research related NHS costs is equally important in order to identify the breadth of studies undertaken by the R&D community in Wales and identify/determine relevant resources to support such studies.
For more information and advice on the Health and Care Research Wales Research Directory please email firstname.lastname@example.org